The team’s work has led to the discovery of an advanced preclinical candidate. Now, Cioffi and Petruhkin have received a $6.4 million grant over five years from the National Institutes of Heath’s National Eye Institute to conduct drug development work and investigational new drug (IND)-enabling toxicology studies.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
